Companies: 10,795·Total market cap: $144.5T

Zura Bio Limited

Zura Bio Limited

ZURANASDAQHealthcare● Active

$3.53

+$0.13(+3.82%)

Market Cap$229527586

P/E Ratio—

52W High$7.44

52W Low$1

Avg Volume631K

Open$3.43

Beta0.03

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Zura Bio Limited（ZURA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ZURA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-1.09Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding94.2MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Zura Bio Limited 数据

分析师预测$15 · Buy

股息不分红

盈利EPS $-1.06-76.67%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$68.7M▼ 31.00% YoY

202320242025

FY 2025EPS$-1.06▼ 76.67% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$75.4MEPS: $-1.09View income statement →

分析师评级与目标价

Buy7 位分析师

Strong Buy

1

Buy

5

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$15.00Low

$3.53Current

$15.00Avg Target上涨空间 324.93%

$15.00High

合计: 7 · 买入占比: 85.7%

根据过去 3 个月内 7 位华尔街分析师，ZURA 共识评级为 Buy，12 个月平均目标价 $15.00 （较现价 $3.53 上涨空间 324.93%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Zura Bio Limited

$3.53+3.82%$229.5M #2

Aardvark Therapeutics, Inc. Common Stock

$3.59-2.45%$78.3M #3

Arcturus Therapeutics Holdings Inc.

$7.12-2.47%$202.4M #4

Assembly Biosciences, Inc.

$22.56-1.51%$358.5M #5

Enanta Pharmaceuticals, Inc.

$11.07-1.86%$257.0M #6

Foghorn Therapeutics Inc.

$3.71-0.54%$217.8M

股票表现

1D+3.82%

1W-13.27%

1M-26.30%

3M-49.35%

YTD-32.63%

1Y+182.40%

5Y-51.24%

关于 Zura Bio Limited

CEOSandeep C. Kulkarni

IPO DateMar 21, 2023

Employees30

CountryUS

Websitezurabio.com

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its ke…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Zura Bio Limited（ZURA）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 21, 2023 在 NASDAQ 上市。截至最近交易日，ZURA 股价为 $3.53，市值约为 $229.5M。过去12个月累计回报 +182.40%，年初至今回报 -32.63%。

根据 7 位华尔街分析师，Zura Bio Limited 股票共识评级为Buy，12个月平均目标价为 $15.00。2025 财年 Zura Bio Limited 营收 —，净利润 -$68.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Zura Bio Limited（ZURA）股价为 $3.53，在 NASDAQ 上市，52周区间为 $1.00 – $7.44。

ZURA 最新股价ZURA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议